Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Q/C Technologies, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 35 | 39 | +4 |
| Shares | 4.81M | 4.70M | −110.8K (−2.3%) |
| Value | $22.4M | $10.3M | −$12.2M (−54.3%) |
New holders (9)
Institutions that held Q/C Technologies, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 18,144 | $39.0K | 0.00% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37.0K | 0.04% |
| Virtu Financial LLC | 16,063 | $35.0K | 0.00% |
| Praetorian Wealth Management, Inc. | 15,000 | $32.0K | 0.01% |
| Jane Street Group, LLC | 12,681 | $28.0K | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15.0K | 0.00% |
| UBS Group AG | 1,077 | $2.00K | 0.00% |
| Allworth Financial LP | 125 | $0 | 0.00% |
| Level Financial Advisors, Inc. | 200 | $0 | 0.00% |
Sold out (5)
Institutions that held Q/C Technologies, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| 683 Capital Management, LLC | 59,410 | $277.0K |
| Qube Research & Technologies Ltd | 20,896 | $97.0K |
| Boothbay Fund Management, LLC | 13,690 | $64.0K |
| Wolverine Trading, LLC | 12,616 | $56.0K |
| Royal Bank of Canada | 585 | $3.00K |